418 related articles for article (PubMed ID: 23296249)
1. Diagnosis and management of polycystic liver disease.
Gevers TJ; Drenth JP
Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):101-8. PubMed ID: 23296249
[TBL] [Abstract][Full Text] [Related]
2. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
Cnossen WR; Drenth JP
Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
[TBL] [Abstract][Full Text] [Related]
3. Treatment of polycystic liver disease. Update on the management.
Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
[TBL] [Abstract][Full Text] [Related]
4. An update on the pathophysiology and management of polycystic liver disease.
Wong MY; McCaughan GW; Strasser SI
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):569-581. PubMed ID: 28317394
[TBL] [Abstract][Full Text] [Related]
5. Polycystic liver disease: a clinical review.
Chandok N
Ann Hepatol; 2012; 11(6):819-26. PubMed ID: 23109444
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: the pathophysiology and management of polycystic liver disease.
Temmerman F; Missiaen L; Bammens B; Laleman W; Cassiman D; Verslype C; van Pelt J; Nevens F
Aliment Pharmacol Ther; 2011 Oct; 34(7):702-13. PubMed ID: 21790682
[TBL] [Abstract][Full Text] [Related]
7. Polycystic Kidney/Liver Disease.
Roediger R; Dieterich D; Chanumolu P; Deshpande P
Clin Liver Dis; 2022 May; 26(2):229-243. PubMed ID: 35487607
[TBL] [Abstract][Full Text] [Related]
8. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
Barten TRM; Bernts LHP; Drenth JPH; Gevers TJG
Expert Opin Ther Targets; 2020 Jun; 24(6):589-599. PubMed ID: 32250187
[No Abstract] [Full Text] [Related]
9. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.
Abu-Wasel B; Walsh C; Keough V; Molinari M
World J Gastroenterol; 2013 Sep; 19(35):5775-86. PubMed ID: 24124322
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic cystic lesions.
Lantinga MA; Gevers TJ; Drenth JP
World J Gastroenterol; 2013 Jun; 19(23):3543-54. PubMed ID: 23801855
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analogues for treatment of polycystic liver disease.
Gevers TJ; Drenth JP
Curr Opin Gastroenterol; 2011 May; 27(3):294-300. PubMed ID: 21191289
[TBL] [Abstract][Full Text] [Related]
12. Management of polycystic liver disease.
Cheung J; Scudamore CH; Yoshida EM
Can J Gastroenterol; 2004 Nov; 18(11):666-70. PubMed ID: 15565206
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
14. [Polycystic liver disease].
Ongaro M; Bronstein FN; Goossens N; Spahr L; Bresson Hadni S
Rev Med Suisse; 2022 Aug; 18(793):1599-1605. PubMed ID: 36047551
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of polycystic liver disease.
Russell RT; Pinson CW
World J Gastroenterol; 2007 Oct; 13(38):5052-9. PubMed ID: 17876869
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.
Masyuk AI; Masyuk TV; Lorenzo Pisarello MJ; Ding JF; Loarca L; Huang BQ; LaRusso NF
Hepatology; 2018 Mar; 67(3):1088-1108. PubMed ID: 29023824
[TBL] [Abstract][Full Text] [Related]
17. Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.
Gevers TJ; Inthout J; Caroli A; Ruggenenti P; Hogan MC; Torres VE; Nevens F; Drenth JP
Gastroenterology; 2013 Aug; 145(2):357-65.e1-2. PubMed ID: 23665274
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targets in Polycystic Liver Disease.
Masyuk TV; Masyuk AI; LaRusso NF
Curr Drug Targets; 2017; 18(8):950-957. PubMed ID: 25915482
[TBL] [Abstract][Full Text] [Related]
19. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
20. Polycystic Liver Disease: Advances in Understanding and Treatment.
Masyuk TV; Masyuk AI; LaRusso NF
Annu Rev Pathol; 2022 Jan; 17():251-269. PubMed ID: 34724412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
